Trade

with

Mela Sciences Inc
(NASDAQ: MELA)
AdChoices
1.95
+0.03
+1.56%
After Hours :
-
-
-

Open

1.93

Previous Close

1.92

Volume (Avg)

12.11k (45.38k)

Day's Range

1.90-2.00

52Wk Range

1.65-10.40

Market Cap.

10.01M

Dividend Rate ( Yield )

-

Beta

0.01

Shares Outstanding

5.21M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 536.00k

    • Net Income

    • -25.95M

    • Market Cap.

    • 10.01M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -3,396.17

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.01

    • Forward P/E

    • -1.48

    • Price/Sales

    • 16.03

    • Price/Book Value

    • 1.40

    • Price/Cash flow

    • -0.51

      • EBITDA

      • -22.94M

      • Return on Capital %

      • -99.09

      • Return on Equity %

      • -156.99

      • Return on Assets %

      • -99.09

      • Book Value/Share

      • 1.37

      • Shares Outstanding

      • 5.21M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 4.50

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -1.30

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 55.90

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -614.52

            • 52.83

            • Pre-Tax Margin

            • -3,396.17

            • 15.96

            • Net Profit Margin

            • -3,396.17

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 1.63

              • 1.97

              • Quick Ratio

              • 0.81

              • 1.16

              • Interest Coverage

              • -84.71

              • 10.47

              • Leverage Ratio

              • 1.75

              • 2.38

              • Book Value/Share

              • 1.37

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -0.53

                • 36.10

                • P/E Ratio 5-Year High

                • -30.07

                • 279.76

                • P/E Ratio 5-Year Low

                • -0.41

                • 148.87

                • Price/Sales Ratio

                • 17.92

                • 3.35

                • Price/Book Value

                • 1.57

                • 4.19

                • Price/Cash Flow Ratio

                • -0.51

                • 17.36

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -156.99

                    (-109.60)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • -99.09

                    (-91.50)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • -155.15

                    (-108.60)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • -

                  • 25.65k

                  • Inventory Turnover

                  • 1.93

                  • 2.66

                  • Asset Turnover

                  • 0.03

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -24.13M
                  Operating Margin
                  -4,502.61
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -0.51
                  Ownership

                  Institutional Ownership

                  15.82%

                  Top 10 Institutions

                  14.89%

                  Mutual Fund Ownership

                  1.68%

                  Float

                  98.71%

                  5% / Insider Ownership

                  27.56%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    53,084

                  • 0.00

                  • 1.02

                  • Mellon Cap Market Completion Strategy

                  •  

                    20,173

                  • 11.66

                  • 0.04

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    11,735

                  • 0.00

                  • 0.23

                  • Vanguard Extended Market Index Fund

                  •  

                    10,211

                  • 0.00

                  • 0.20

                  • USAA Extended Market Index Fund

                  •  

                    7,815

                  • -0.04

                  • 0.01

                  • Fidelity Spartan® Total Market Idx Fund

                  •  

                    4,011

                  • 0.00

                  • 0.08

                  • The Vanguard - Total Stk Mkt Idx Trust. CF

                  •  

                    3,270

                  • 0.00

                  • 0.06

                  • Vanguard US Equity Index

                  •  

                    3,000

                  • 0.00

                  • 0.01

                  • Vanguard Instl Total Stock Market Index

                  •  

                    948

                  • 0.00

                  • 0.02

                  • Master Extended Market Index Series

                  •  

                    782

                  • 0.00

                  • 0.01

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Sabby Management LLC

                  •  

                    3,288,019

                  • -11.72%

                  • 6.31

                  • BlackRock Fund Advisors

                  •  

                    2,642,328

                  • +1.88%

                  • 5.07

                  • Vanguard Group, Inc.

                  •  

                    687,738

                  • 0.00%

                  • 1.32

                  • California Public Employees Retrmnt Sys

                  •  

                    225,700

                  • 0.00%

                  • 0.43

                  • Allen Holding Inc

                  •  

                    188,665

                  • 0.00%

                  • 0.36

                  • Geode Capital Management, LLC

                  •  

                    160,555

                  • 0.00%

                  • 0.30

                  • BNY Mellon Asset Management Ltd.

                  •  

                    82,140

                  • +0.28%

                  • 0.16

                  • Goldman, Sachs & Co.

                  •  

                    77,954

                  • +33.93%

                  • 0.15

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Distressed

                  Style

                  Small Growth

                  Mela Sciences Inc was incorporated in the State of New York in December 1989 under the name Electro-Optical Sciences, Inc. and subsequently reincorporated under the laws of the State of Delaware in 1997. In April 2010, it changed its...more name to MELA Sciences, Inc. The Company is a medical device company focused on the commercialization of its flagship product, MelaFind, the further design and development of MelaFind and its technology. MelaFind is a non-invasive, point-of-care instrument to aid in the detection of melanoma. The MelaFind system produces a report at the point-of-care to assist in the diagnostic process. MelaFind employs light of multiple wavelengths to obtain data from clinically atypical lesions; and then the data are analyzed against its proprietary database of melanomas and benign les...moreions using its sophisticated algorithms. The Company competes with other imaging modalities, including molecular imaging in which tagged antibodies search for cancer cell antigens, and with molecular and genetic screening tests. The sale and marketing of MelaFind is subject to a complex system of federal and state laws and regulations intended to deter, detect, and respond to fraud and abuse in the healthcare system.lessless

                  Key People

                  Ms. Rosemary A. Crane

                  CEO/Director/President

                  Robert W. Cook

                  CFO/Secretary/Treasurer

                  Anthony J. Dimun

                  Director

                  David K. Stone

                  Director

                  LuAnn Via

                  Director

                  • Mela Sciences Inc

                  • 50 South Buckhout Street

                  • Irvington, NY 10533

                  • USA.Map

                  • Phone: +1 914 591-3783

                  • Fax: +1 914 591-3785

                  • melasciences.com

                  Incorporated

                  1989

                  Employees

                  50

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: